Journal of Agricultural and Food Chemistry
Article
white solid, mp 108−109 °C. 1H NMR (400 MHz, CDCl3) δ 3.84−3.67
(m, 2H), 2.86−2.76 (m, 3H), 2.66 (t, J = 12.0 Hz, 1H), 2.37−2.31 (m,
2H), 2.25 (dd, J = 8.0, 4.1 Hz, 1H), 2.01−1.86 (m, 7H), 1.81−1.48 (m,
6H), 1.44−1.25 (m, 4H), 1.11−1.00 (m, 1H). 13C NMR (100 MHz,
CDCl3) δ 64.4, 58.5, 57.8, 57.6, 57.4, 56.1, 47.2, 41.5, 36.8, 35.1, 28.3,
26.5, 26.2, 24.8, 21.8, 21.4. HRMS (ESI) calcd. for [C16H27ClN2+H]+
283.1936, found 283.1940.
Synthetic Procedure for 14-S-14-Chloromethyl-15-deoxymatrine
(6). Compound 6 was obtained using a synthetic procedure similar to
that of compound 5 as a white solid (0.58 g, 71%), mp 57−58 °C. 1H
NMR (400 MHz, CDCl3) δ 3.43−3.31 (m, 2H), 3.00 (d, J = 8.0 Hz,
1H), 3.01−2.76 (m, 3H), 2.42−2.34 (m, 2H), 2.05−1.89 (m, 9H),
1.78−1.60 (m, 2H), 1.55 (s, 2H), 1.46−1.31 (m, 4H), 1.11−0.96 (m,
2H). 13C NMR (100 MHz, CDCl3) δ 64.2, 59.8, 57.9, 57.6, 57.3, 56.0,
48.2, 41.6, 38.7, 35.6, 29.1, 29.0, 28.1, 26.5, 21.7, 21.3. HRMS (ESI)
calcd. for [C16H27ClN2+H]+ 283.1936, found 283.1940.
Synthetic Procedure for 14-R-14-Methylsulfonyloxymethyl-15-
deoxymatrine (7). To a solution of compound 3 (0.69 g, 2.6 mmol)
and in CH2Cl2 (40 mL) was added methylsulfonyl chloride (0.59 g,
5.2 mmol) dropwise at room temperature. After the reaction mixture
was stirred at room temperature for about 2.5 h, it was washed with
diluted aqueous NaHCO3, water, and brine. After the solution was dried
over anhydrous Na2SO4, it was evaporated under reduced pressure, and
the resulting residue was purified by column chromatography on
alkaline alumina to give compound 7 as a white solid (0.94 g, 80%), mp
106−107 °C. 1H NMR (400 MHz, CDCl3) δ 4.48−4.35 (m, 2H), 3.02
(s, 3H), 2.84−2.65 (m, 4H), 2.39−2.34 (m, 2H), 2.20 (dd, J = 8.0,
4.0 Hz, 1H), 2.10−2.08 (m, 1H), 2.01 (t, J = 4.0 Hz, 1H), 1.93−1.70 (m,
7H), 1.60−1.49 (m, 3H), 1.45−1.26 (m, 5H), 1.13−1.02 (m, 1H). 13C
NMR (100 MHz, CDCl3) δ 71.6, 64.2, 58.3, 57.6, 57.4, 56.5, 56.0, 41.5,
36.9, 35.1, 33.4, 28.2, 26.2, 25.1, 24.9, 21.7, 21.3. HRMS (ESI) calcd. for
[C17H30N2O3S+H]+ 343.2050, found 343.2058.
Synthetic Procedure for 14-S-14-Methylsulfonyloxymethyl-15-
deoxymatrine (8). Compound 8 was obtained by using compound 4
as substrate and adopting a synthetic procedure similar to that of
compound 7 as a white solid (0.92 g, 90%), mp 110−112 °C. 1H NMR
(400 MHz, CDCl3) δ 4.11−3.98 (m, 2H), 3.01 (s, 3H), 2.94−2.91 (m,
1H), 2.84−2.74 (m, 3H), 2.40−2.34 (m, 2H), 2.05−2.04 (m, 2H),
1.99−1.84 (m, 7H), 1.77−1.62 (m, 2H), 1.56−1.47 (m, 2H), 1.47−1.31
(m, 4H), 1.12−1.04 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 72.4,
64.0, 58.5, 57.8, 57.4, 57.2, 55.9, 41.4, 37.2, 36.0, 35.1, 28.6, 28.1, 27.2,
26.3, 21.5, 21.2. HRMS (ESI) calcd. for [C17H30N2O3S+H]+ 343.2050,
found 343.2054.
ammonia and petroleum ether (volume ratio 1:1) as eluent. The
crude yield could reach 82% (separation yield of 3 was 37%, that
of 4 was 35%), which ensured further diversity derivation. With
optically pure substrates 3 and 4 in hand, a series of sulfate, car-
boxylate, and heterocycle carboxylate was synthesized (Figure 2)
by reacting 3 or 4 with corresponding sulfonyl chloride or
acyl chlorides (Figure 3); chlorinated matrines 5 and 6 were
synthesized by refluxing 3 and 4, respectively, with thionyl
chloride.
Configuration of 3 and 4. The absolute configurations of
1
14-C of 3 and 4 were difficult to assign through the H NMR
spectra analysis, so we decided to analyze the configurations of
intermediate B1 and B2 to deduce the configurations of 3 and 4.
Though B1 and B2 could not be separated by column chroma-
tography as we previously described, by repeated recrystalliza-
tion (ethyl acetate, petroleum ether), they can be obtained as
mixtures with ratios about 3:1 (mixture I) and 1:1 (mixture II).
By comparing the NOE difference spectrum of mixture II
1
(Figure S1) and H NMR spectra of mixture I and mixture II
and 14-H (peak c) of B1 were at the same side of the pyridinone
ring, which indicated a 14-R configuration. Hence, by reducing
mixture I and comparing the obtained quantities of the two
products, we could assign compound 3 in higher separation yield
to be the one reduced from B1, therefore also bearing a 14-R
configuration.
Though we did not obtain the crystal of 3 or 4 or any one of
their derivatives at the beginning of our project, we fortunately
obtained the single-crystal of compound 2 in its dihydrate form.
In fact, X-ray diffraction of compound 2 not only well explained
the extra peaks around 4.10 ppm in 1H NMR spectrum, but also
clarified the spatial configuration of 1,16-dioxy-15-deoxymatrine
(Figure 3 and Figure S4), which could be used to deduce the
configuration of compounds 3 and 4. Since we could know from
Figure S4 that the oxygen atom at N1 was at the trans position to
the hydrogen at C5 (numbering in the X-ray drawing of 2), we
could deduce that in compounds 3 and 4 the lone pair electrons
at N1 are also trans to the hydrogen at C11 (C5 in the X-ray
drawing of 2). Therefore, in compound 3, the hydroxymethyl
group is at the same direction with the lone pair electrons, and
they should form intramolecular hydrogen bond (Figure S5);
thus, 3 should have less polarity and occur in the upper position
on TLC plate. That is truly the case. Fortunately, we finally
obtained the single crystal of compound 17 (Figure S6), a deriv-
ative of compound 3, which proved the correctness of con-
figuration assignment of compounds 3 and 4.
Compounds 9−32 were prepared similarly by reacting 3 or 4 with
corresponding sulfonyl chloride or acyl chloride. The physical data were
Biological Assay. Detailed bioassay procedures for the anti-TMV,22
fungicidal,23 and insecticidal24 activities were described in our published
ing to statistical requirements, each bioassay was repeated at least three
times. The error of the experiments was 5%.
Antiviral Activity. A series of matrine analogues was
synthesized and assessed the antivirus activity against tobacco
mosaic virus (TMV) in four modes (in vitro, inactivation effect,
curative effect, and protection effect in vivo), with commercial
ribavirin and NK-007, an efficient antivirus compound created by
our group previously, as standards (Table 1). Compared with
matrine, compound 1 had increased anti-TMV activity more or
less after reducing the amide in matrine to tertiary amine, and
when both nitrogen atoms were oxidized, 2 had decreased
activity (1 > matrine > 2), which indicated that the lone pair
electrons of the two nitrogen atoms was beneficial to the activity.
The 14-hydroxymethyl-15-deoxymatrine was a pair of diaster-
eoisomers, of which the one in 14-R configuration was 3, and
the one in 14-S was 4. The two compounds had remarkable
differences: the activity of 3 (67.3%, 69.2%, 63.7%, 63.0% at
500 μg/mL for in vitro activity, inactivation, curative and protec-
tion activities in vivo, respectively) was approximately equal to
RESULTS AND DISCUSSION
■
Synthesis. Compound 1 was synthesized by reducing
matrine with LiAlH4, and compound 2 was made by oxidation
of 1 with hydrogen peroxide (Figure 3). The optically pure
substrates 3 and 4 needed a three-step reaction. The first step was
to synthesize compound A by reacting matrine with dimethyl
carbonate in the presence of LDA at −78 °C. Compound A was a
mixture of two diastereomers, but the two isomers could not be
separated by column chromatography because they had almost
the same polarity and occurred at the same place on the TLC
plate. In the second step, compound A reacted with sodium boro-
hydride to afford compound B. Similarly, the two diastereomers of
B could not be separated due to a situation just like compound A.
At last, compound B was treated with LiAlH4 to give the iso-
mers 3 and 4, which were successfully separated on an alkaline
alumina column using methylene chloride with 1% aqueous
E
J. Agric. Food Chem. XXXX, XXX, XXX−XXX